$LGND.US Ranked Positive On May 14th, 2025
Ligand Pharmaceuticals Inc (LGND US, +1, 14-May-25) Todd Davis (CEO since 2022, Non Exec from 2007-2022) purchased $1m of stock on the 9th May at $105.20, increasing his stake by 6%. This is a notable buy from an insider with an excellent record as both a buyer and seller. This purchase is more than 4x larger than any […]